MENU
SEPN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Septerna (SEPN) Ownership - Who owns Septerna?
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
521.65M
P/E Ratio
N/A
Total Cash
326.56M
Projected Growth
N/A
Total Debt
24.57M
Revenue
726K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.32
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
Fundamentals
SEPN
Capitalization
522M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
327M
Total Cash/Share
7.32
Total Debt
24.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
726K
ROE
N/A
Book Value
378M
P/B Ratio
1.38
Cash Flow
N/A
Earnings
-7.58
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
45K
Current Ratio
22.09
Current Revenue Per Employee
1586.67
Dividends Per Share - Security
N/A
EBITDA
-100.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-29.57
Shares Held By Institutions
371M
Shares Outstanding - Current
44.6M
Total Liabilities
37.7M
Total Volume MTD
N/A
Value
-1
Gain YTD
-48.908
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SEPN showed earnings on August 11, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information